- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cumberland Pharmaceuticals Inc (CPIX)
Cumberland Pharmaceuticals Inc stock price live, this page displays NASDAQ CPIX stock exchange data. View the CPIX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cumberland Pharmaceuticals Inc real time stock price chart below.
What Is the Cumberland Pharmaceuticals Inc Stock Price Today?
The Cumberland Pharmaceuticals Inc stock price today is 3.230.
What Is the Stock Symbol for Cumberland Pharmaceuticals Inc?
The stock symbol for Cumberland Pharmaceuticals Inc is ""CPIX.""
What Stock Exchange Does Cumberland Pharmaceuticals Inc Trade On?
Cumberland Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Cumberland Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Cumberland Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CPIX quote. (ISIN: US2307701092)
What Is the Cumberland Pharmaceuticals Inc Stock Price Today?
The Cumberland Pharmaceuticals Inc stock price today is 3.230.
What Is the Stock Symbol for Cumberland Pharmaceuticals Inc?
The stock symbol for Cumberland Pharmaceuticals Inc is ""CPIX.""
What Stock Exchange Does Cumberland Pharmaceuticals Inc Trade On?
Cumberland Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Cumberland Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Cumberland Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CPIX quote. (ISIN: US2307701092)
NASDAQ
Currency in USD
3.230
-0.050(-1.52%)
Closed·
After Hours
3.290+0.060(+1.86%)
·
Fair Value
An estimate of a Cumberland's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.180
3.488
52 wk Range
1.040
7.250
CPIX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CPIX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Cumberland's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.1803.488
52 wk Range
1.0407.250
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CPIX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Cumberland's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Cumberland Pharmaceuticals Inc Company Profile
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, an injection for the prevention of nausea and vomiting for patients receiving chemotherapy treatment; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of the cardiomyopathy associate with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, and aspirin-exacerbated respiratory disease; and is in Phase II clinical trial for the treatment of systemic sclerosis and idiopathic pulmonary fibrosis. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Cumberland Pharmaceuticals Inc Earnings Call Summary for Q2/2025
- Q2 2025 revenue up 10% YoY to $10.8M; EPS loss of $0.02 missed expectations, leading to 5.49% stock drop to $4.01 in aftermarket trading
- Year-to-date revenue reached $22.6M, up 23% YoY; adjusted earnings of $400,000 for Q2; cash flow from operations at $4.7M
- Company maintains 'GOOD' financial health score of 2.86; focus on international expansion and product innovation continues
- FY 2026 guidance anticipates challenges with EPS forecast at -$0.43; CEO emphasizes dedication to improving patient care through unique products
- No questions asked during earnings call, potentially leaving investor concerns unaddressed
Last Updated: 05/08/2025, 22:38
Read Full TranscriptCompare CPIX to Peers and Sector
Metrics to compare | CPIX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCPIXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −16.5x | −3.0x | −0.5x | |
PEG Ratio | −0.23 | 0.09 | 0.00 | |
Price/Book | 1.7x | −0.9x | 2.6x | |
Price / LTM Sales | 1.1x | 4.2x | 3.3x | |
Upside (Analyst Target) | - | 89.9% | 43.4% | |
Fair Value Upside | Unlock | 9.1% | 7.1% | Unlock |
Earnings
Latest Release
Aug 05, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
10.80M / --
People Also Watch
FAQ
What Stock Exchange Does Cumberland Trade On?
Cumberland is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Cumberland?
The stock symbol for Cumberland is "CPIX."
What Is the Cumberland Market Cap?
As of today, Cumberland market cap is 48.32M.
What Is Cumberland's Earnings Per Share (TTM)?
The Cumberland EPS (TTM) is -0.20.
From a Technical Analysis Perspective, Is CPIX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Cumberland Stock Split?
Cumberland has split 0 times.
How Many Employees Does Cumberland Have?
Cumberland has 91 employees.
What is the current trading status of Cumberland (CPIX)?
As of 10 Aug 2025, Cumberland (CPIX) is trading at a price of 3.23, with a previous close of 3.28. The stock has fluctuated within a day range of 3.18 to 3.49, while its 52-week range spans from 1.04 to 7.25.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.